132 related articles for article (PubMed ID: 17209527)
1. Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative.
Roche M; Kyriakou H; Seiden M
Curr Opin Investig Drugs; 2006 Dec; 7(12):1092-9. PubMed ID: 17209527
[TBL] [Abstract][Full Text] [Related]
2. Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer.
Wilkes GM
Oncology (Williston Park); 2010 Oct; 24(10 Suppl):46-8. PubMed ID: 21275327
[No Abstract] [Full Text] [Related]
3. Taxoids: cancer-fighting compounds from nature.
Kingston DG; Newman DJ
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):130-44. PubMed ID: 17436548
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel poliglumex. Cell Therapeutics/Chugai Pharmaceutical.
Man M; Rugo H
IDrugs; 2005 Sep; 8(9):739-54. PubMed ID: 16118697
[TBL] [Abstract][Full Text] [Related]
5. [Cost-benefit aspects of taxane therapy].
Dietrich ES
Pharm Unserer Zeit; 2005; 34(2):138-47. PubMed ID: 15803798
[No Abstract] [Full Text] [Related]
6. Drug evaluation: Bay-59-8862.
Eckstein JW
IDrugs; 2004 Jun; 7(6):575-81. PubMed ID: 15197663
[TBL] [Abstract][Full Text] [Related]
7. [Paclitaxel and docetaxel safe use: pharmacokinetics and potential interactions of taxanes].
Simons S; Jaehde U
Pharm Unserer Zeit; 2005; 34(2):122-7. PubMed ID: 15803796
[No Abstract] [Full Text] [Related]
8. Taxanes.
Nurs Times; 2006 Jul 25-31; 102(30):37. PubMed ID: 16903306
[No Abstract] [Full Text] [Related]
9. Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.
Singer JW
J Control Release; 2005 Dec; 109(1-3):120-6. PubMed ID: 16297482
[TBL] [Abstract][Full Text] [Related]
10. Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes.
Wang Y; Tomlinson B
Curr Opin Investig Drugs; 2007 Oct; 8(10):849-58. PubMed ID: 17907062
[TBL] [Abstract][Full Text] [Related]
11. DU-176b, an oral, direct Factor Xa antagonist.
Hylek E
Curr Opin Investig Drugs; 2007 Sep; 8(9):778-83. PubMed ID: 17729190
[TBL] [Abstract][Full Text] [Related]
12. [The action and toxicity of taxanes].
Lipp HP; Bokemeyer C
Pharm Unserer Zeit; 2005; 34(2):128-37. PubMed ID: 15803797
[No Abstract] [Full Text] [Related]
13. [Level of evidence for therapeutic drug monitoring for docetaxel].
Gerritsen-van Schieveen P; Royer B;
Therapie; 2010; 65(3):201-6. PubMed ID: 20699071
[TBL] [Abstract][Full Text] [Related]
14. The epothilones: how pharmacology relates to clinical utility.
Michaud LB
Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
[TBL] [Abstract][Full Text] [Related]
15. Taxane pathway.
Oshiro C; Marsh S; McLeod H; Carrillo MW; Klein T; Altman R
Pharmacogenet Genomics; 2009 Dec; 19(12):979-83. PubMed ID: 21151855
[No Abstract] [Full Text] [Related]
16. Drug evaluation: sapacitabine--an orally available antimetabolite in the treatment of cancer.
Galmarini CM
Curr Opin Investig Drugs; 2006 Jun; 7(6):565-73. PubMed ID: 16784028
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development].
Volkov NM; Moiseenko VM
Vopr Onkol; 2007; 53(4):383-92. PubMed ID: 17969398
[No Abstract] [Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Prasugrel, a third generation thienopyridine and potent platelet inhibitor.
Gurbel PA; Tantry US
Curr Opin Investig Drugs; 2008 Mar; 9(3):324-36. PubMed ID: 18311669
[TBL] [Abstract][Full Text] [Related]
20. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
